Login / Signup

Natalizumab treatment and pregnancy in multiple sclerosis: A reappraisal of maternal and infant outcomes after 6 years.

Emilio PortaccioLuisa PastòLorenzo RazzoliniLucia MoiolaVittorio MartinelliPietro AnnovazziAngelo GhezziMauro ZaffaroniRoberta LanzilloVincenzo Brescia MorraFrancesca RinaldiPaolo GalloClaudio GasperiniDamiano PaolicelliMarta SimoneCarlo PozzilliLaura De GiglioPaola CavallaEleonora CoccoMaria Giovanna MarrosuFrancesco PattiClaudio SolaroGiancarlo ComiMassimo FilippiMaria TrojanoMaria Pia Amato
Published in: Multiple sclerosis (Houndmills, Basingstoke, England) (2022)
Our data confirm that TA reduces the risk of disease activity; we did not observe an increase in major development abnormalities in the child.
Keyphrases